• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院成年人中,严重 COVID-19 的风险因素因年龄而异。

Risk factors for severe COVID-19 differ by age for hospitalized adults.

机构信息

Institute for Systems Biology, 401 Terry Ave N, Seattle, WA, 98109, USA.

Washington University School of Medicine, St. Louis, MO, 63110, USA.

出版信息

Sci Rep. 2022 Apr 28;12(1):6568. doi: 10.1038/s41598-022-10344-3.

DOI:10.1038/s41598-022-10344-3
PMID:35484176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9050669/
Abstract

Risk stratification for hospitalized adults with COVID-19 is essential to inform decisions about individual patients and allocation of resources. So far, risk models for severe COVID outcomes have included age but have not been optimized to best serve the needs of either older or younger adults. Models also need to be updated to reflect improvements in COVID-19 treatments. This retrospective study analyzed data from 6906 hospitalized adults with COVID-19 from a community health system across five states in the western United States. Risk models were developed to predict mechanical ventilation illness or death across one to 56 days of hospitalization, using clinical data available within the first hour after either admission with COVID-19 or a first positive SARS-CoV-2 test. For the seven-day interval, models for age ≥ 18 and < 50 years reached AUROC 0.81 (95% CI 0.71-0.91) and models for age ≥ 50 years reached AUROC 0.82 (95% CI 0.77-0.86). Models revealed differences in the statistical significance and relative predictive value of risk factors between older and younger patients including age, BMI, vital signs, and laboratory results. In addition, for hospitalized patients, sex and chronic comorbidities had lower predictive value than vital signs and laboratory results.

摘要

对住院的 COVID-19 成年患者进行风险分层对于告知患者个体和资源分配决策至关重要。到目前为止,严重 COVID 结局的风险模型包括年龄,但尚未经过优化以最好地满足老年或年轻成年人的需求。模型还需要更新,以反映 COVID-19 治疗方法的改进。本回顾性研究分析了来自美国西部五个州一个社区卫生系统的 6906 名住院 COVID-19 成年患者的数据。使用 COVID-19 入院或首次 SARS-CoV-2 检测呈阳性后第一小时内可用的临床数据,开发了预测机械通气疾病或住院后 1 至 56 天内死亡的风险模型。对于 7 天的间隔,年龄≥18 岁且<50 岁的模型的 AUROC 为 0.81(95%CI 0.71-0.91),年龄≥50 岁的模型的 AUROC 为 0.82(95%CI 0.77-0.86)。模型揭示了年龄、BMI、生命体征和实验室结果等危险因素在老年和年轻患者之间的统计学意义和相对预测价值的差异。此外,对于住院患者,性别和慢性合并症的预测价值低于生命体征和实验室结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4e/9050669/fc629d67bf9e/41598_2022_10344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4e/9050669/9f02086df98a/41598_2022_10344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4e/9050669/fc629d67bf9e/41598_2022_10344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4e/9050669/9f02086df98a/41598_2022_10344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf4e/9050669/fc629d67bf9e/41598_2022_10344_Fig2_HTML.jpg

相似文献

1
Risk factors for severe COVID-19 differ by age for hospitalized adults.住院成年人中,严重 COVID-19 的风险因素因年龄而异。
Sci Rep. 2022 Apr 28;12(1):6568. doi: 10.1038/s41598-022-10344-3.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.严重 COVID-19 适应性风险预测器(SCARP)的开发,是一种用于预测 COVID-19 住院患者发生严重疾病或死亡的计算器。
Ann Intern Med. 2021 Jun;174(6):777-785. doi: 10.7326/M20-6754. Epub 2021 Mar 2.
4
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.成人因实验室确诊的 COVID-19 住院的严重程度在 SARS-CoV-2 B.1.617.2(Delta)流行之前和期间-COVID-NET,14 个州,2021 年 1 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.
5
Predictors at Admission of Mechanical Ventilation and Death in an Observational Cohort of Adults Hospitalized With Coronavirus Disease 2019.COVID-19 成年住院患者机械通气和死亡的入院预测因素的观察性队列研究。
Clin Infect Dis. 2021 Dec 6;73(11):e4141-e4151. doi: 10.1093/cid/ciaa1459.
6
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
7
Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.比较在蒙特利尔居住在和未居住在长期护理院的 COVID-19 住院患者:一项回顾性病例系列研究。
CMAJ Open. 2021 Jul 13;9(3):E718-E727. doi: 10.9778/cmajo.20200244. Print 2021 Jul-Sep.
8
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States.美国11721例2019冠状病毒病(COVID-19)住院患者的特征及预后
Clin Infect Dis. 2021 May 18;72(10):e558-e565. doi: 10.1093/cid/ciaa1268.
9
Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group.美国东南部地区导致 COVID-19 患者死亡和病情恶化的风险因素:来自 SEUS 研究组的报告。
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1464-1472. doi: 10.1017/ice.2020.1435. Epub 2021 Jan 11.
10
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.体重指数和年龄与 COVID-19 住院患者发病率和死亡率的关系:美国心脏协会 COVID-19 心血管疾病登记研究结果。
Circulation. 2021 Jan 12;143(2):135-144. doi: 10.1161/CIRCULATIONAHA.120.051936. Epub 2020 Nov 17.

引用本文的文献

1
Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru.秘鲁住院的未接种疫苗的新冠肺炎患者体内抗新冠病毒 2 型抗体的动力学及血液学参数
PeerJ. 2025 Aug 22;13:e19771. doi: 10.7717/peerj.19771. eCollection 2025.
2
Healthcare resource use and costs among patients with COVID-19 in the United States.美国新冠肺炎患者的医疗资源使用情况及费用
BMC Health Serv Res. 2025 Jul 3;25(1):909. doi: 10.1186/s12913-025-12878-4.
3
Long-Term Clinical Outcomes of Adults Hospitalized for COVID-19 Pneumonia.

本文引用的文献

1
External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals.COVID-19 预后评分的外部验证:大巴黎大学医院住院患者的多中心队列研究。
Intensive Care Med. 2021 Dec;47(12):1426-1439. doi: 10.1007/s00134-021-06524-w. Epub 2021 Sep 28.
2
Accuracy of the Veterans Health Administration COVID-19 (VACO) Index for predicting short-term mortality among 1307 US academic medical centre inpatients and 427 224 US Medicare patients.退伍军人事务部 COVID-19(VACO)指数预测美国 1307 家学术医疗中心住院患者和 427224 名美国医疗保险患者短期死亡率的准确性。
J Epidemiol Community Health. 2022 Mar;76(3):254-260. doi: 10.1136/jech-2021-216697. Epub 2021 Sep 28.
3
因新冠肺炎肺炎住院的成年人的长期临床结局
Emerg Infect Dis. 2025 Jun;31(6):1158-1168. doi: 10.3201/eid3106.241097.
4
Age-Stratified Risk of Severe COVID-19 for People With Disabilities in Korea: Nationwide Study Considering Disability Type.韩国残疾人士中按年龄分层的重症新冠风险:考虑残疾类型的全国性研究
J Korean Med Sci. 2025 Feb 24;40(7):e37. doi: 10.3346/jkms.2025.40.e37.
5
Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis.老年新冠病毒肺炎患者的免疫学特征:新冠后时代分析
Front Cell Infect Microbiol. 2024 Nov 29;14:1450196. doi: 10.3389/fcimb.2024.1450196. eCollection 2024.
6
Effect of the COVID-19 pandemic on the well-being of middle-aged and older Europeans.COVID-19 大流行对欧洲中老年人福祉的影响。
Sci Rep. 2024 Oct 28;14(1):25796. doi: 10.1038/s41598-024-74429-x.
7
DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters.中度和重度 COVID-19 病例中的 DNA 损伤:与人口统计学、临床和实验室参数的关系。
Int J Mol Sci. 2024 Sep 24;25(19):10293. doi: 10.3390/ijms251910293.
8
Association of COVID-19 with acute and post-acute risk of multiple different complications and mortality in patients infected with omicron variant stratified by initial disease severity: a cohort study in Hong Kong.奥密克戎变异株感染患者中,按初始疾病严重程度分层的 COVID-19 与多种不同并发症和死亡的急性和亚急性风险的相关性:香港的一项队列研究。
BMC Med. 2024 Oct 14;22(1):461. doi: 10.1186/s12916-024-03630-6.
9
Feature Identification Using Interpretability Machine Learning Predicting Risk Factors for Disease Severity of In-Patients with COVID-19 in South Florida.利用可解释性机器学习识别南佛罗里达州新冠肺炎住院患者疾病严重程度风险因素的特征
Diagnostics (Basel). 2024 Aug 26;14(17):1866. doi: 10.3390/diagnostics14171866.
10
An Albumin, Neutrophil, and Lymphocyte-Related Risk Estimation Tool in Hospitalised Patients.住院患者白蛋白、中性粒细胞和淋巴细胞相关风险评估工具
Cureus. 2024 Jul 9;16(7):e64197. doi: 10.7759/cureus.64197. eCollection 2024 Jul.
Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors.衰老与 COVID-19 易感性、疾病严重程度和临床结局:纠缠风险因素的作用。
Exp Gerontol. 2021 Oct 15;154:111507. doi: 10.1016/j.exger.2021.111507. Epub 2021 Aug 3.
4
Predicting critical state after COVID-19 diagnosis: model development using a large US electronic health record dataset.预测新冠病毒疾病诊断后的危急状态:利用美国大型电子健康记录数据集进行模型开发
NPJ Digit Med. 2021 Jul 20;4(1):113. doi: 10.1038/s41746-021-00482-9.
5
Lifting of COVID-19 restrictions in the UK and the Delta variant.英国新冠疫情限制措施的解除与德尔塔变种
Lancet Respir Med. 2021 Aug;9(8):e85. doi: 10.1016/S2213-2600(21)00328-3. Epub 2021 Jul 12.
6
Ambulatory Risk Models for the Long-Term Prevention of Sepsis: Retrospective Study.用于脓毒症长期预防的门诊风险模型:回顾性研究
JMIR Med Inform. 2021 Jul 8;9(7):e29986. doi: 10.2196/29986.
7
Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients.基于机器学习的住院 COVID-19 患者疾病严重程度评分和分类模型的建立。
PLoS One. 2021 Apr 21;16(4):e0240200. doi: 10.1371/journal.pone.0240200. eCollection 2021.
8
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications.新型冠状病毒肺炎相关低钙血症:患病率、临床意义及治疗影响。
Rev Endocr Metab Disord. 2022 Apr;23(2):299-308. doi: 10.1007/s11154-021-09655-z. Epub 2021 Apr 13.
9
COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19.COVID-IRS:一种新型预测评分,用于预测 COVID-19 患者接受有创机械通气的风险。
PLoS One. 2021 Apr 5;16(4):e0248357. doi: 10.1371/journal.pone.0248357. eCollection 2021.
10
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients.一种基于基线风险因素的风险评分,用于预测新冠肺炎患者的死亡率。
Curr Med Res Opin. 2021 Jun;37(6):917-927. doi: 10.1080/03007995.2021.1904862. Epub 2021 Apr 10.